Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical
Review, Evidence-Based Clinical Guidance and Unmet Needs
Authors
Keywords
-
Journal
PHARMACOPSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2022-07-02
DOI
10.1055/a-1854-0185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review
- (2021) Christoph U. Correll et al. World Psychiatry
- Addressing negative symptoms of schizophrenia pharmacologically with cariprazine: evidence from clinical trials, a real-world study, and clinical cases
- (2021) György Németh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia
- (2021) Stefan Leucht et al. JAMA Psychiatry
- Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis
- (2021) Cristina Mei et al. CLINICAL PSYCHOLOGY REVIEW
- Drugs do not work if patients do not take them
- (2021) Fergus E. Brown et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review
- (2020) Sanne M. Kloosterboer et al. Expert Opinion On Drug Safety
- Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
- (2020) Marco Solmi et al. World Psychiatry
- Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis
- (2020) Javier-David Lopez-Morinigo et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies
- (2019) D. Papola et al. ACTA PSYCHIATRICA SCANDINAVICA
- Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data
- (2019) Daniele Piovani et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Suicide Rates Among Adolescents and Young Adults in the United States, 2000-2017
- (2019) Oren Miron et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Dose-related concentrations of neuro-/psychoactive drugs expected in blood of children and adolescents
- (2019) S Fekete et al. THERAPEUTIC DRUG MONITORING
- Insight and psychosis: the next 30 years
- (2019) Anthony S. David BRITISH JOURNAL OF PSYCHIATRY
- Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
- (2019) Celso Arango et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials
- (2018) Lei Xia et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
- (2018) Sameer Jauhar et al. MOLECULAR PSYCHIATRY
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis
- (2018) Christoph U. Correll et al. JAMA Psychiatry
- Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis
- (2018) Pierre Ellul et al. CNS DRUGS
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis
- (2017) Anne Katrine Pagsberg et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
- (2017) C. Hiemke et al. PHARMACOPSYCHIATRY
- Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
- (2016) Eric Druyts et al. BMC Pediatrics
- Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
- (2016) Robin M. Murray et al. BRITISH JOURNAL OF PSYCHIATRY
- A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
- (2016) Rebecca C. Harvey et al. CNS DRUGS
- Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry
- (2016) Manfred Gerlach et al. Expert Opinion On Drug Safety
- Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry
- (2016) Julie Vestergaard Braüner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents
- (2016) Aditya N Sharma et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment
- (2016) Leonardo Tondo et al. Current Psychiatry Reports
- Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)
- (2015) G.H.M. Pijnenborg et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
- (2015) Antonio M. Persico et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review
- (2015) Zachary Whitney et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Neurological Adverse Effects of Antipsychotics in Children and Adolescents
- (2015) Margarita Garcia-Amador et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients
- (2014) Celso Arango et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Excess Early Mortality in Schizophrenia
- (2013) Thomas Munk Laursen et al. Annual Review of Clinical Psychology
- Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone
- (2013) Takeshi Murai et al. BEHAVIOURAL BRAIN RESEARCH
- Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
- (2013) C. Schneider et al. EUROPEAN PSYCHIATRY
- Antipsychotics in children and adolescents with schizophrenia: A systematic review and meta-analysis
- (2013) Sandeep Grover et al. INDIAN JOURNAL OF PHARMACOLOGY
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
- (2013) Jon McClellan et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Changes in insight during treatment for psychotic disorders: A meta-analysis
- (2013) Gerdina H.M. Pijnenborg et al. SCHIZOPHRENIA RESEARCH
- Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries
- (2012) Antonio Lora et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
- (2012) Jian-Ping Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Evidence-Based Medicine Versus Personalized Medicine
- (2012) Jose de Leon JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents
- (2012) David Cohen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children
- (2011) Tamara Pringsheim et al. DRUG SAFETY
- Management of Schizophrenia in Children and Adolescents
- (2011) Gabriele Masi et al. DRUGS
- Clinical Usefulness of Second-Generation Antipsychotics in Treating Children and Adolescents Diagnosed with Bipolar or Schizophrenic Disorders
- (2011) Salvatore Gentile PEDIATRIC DRUGS
- Adolescent inpatient psychiatric admission rates and subsequent one-year mortality in England: 1998-2004
- (2010) Anthony James et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Olanzapine compared to quetiapine in adolescents with a first psychotic episode
- (2009) Celso Arango et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started